Oneview Healthcare Plc

ONE.ASX

Health Care

Provider of software platforms to healthcare organisations and patients to make use of technology to drive cost efficiencies, improve clinical outcomes and enhance patient satisfaction and quality of healthcare.

Market Data

Price

$0.180

+0.0%
Market Cap

$151.0M

P/E Ratio

-100000.0x

EPS

$-0.027

Div. Yield

0.00%

52-Week Change

-0.4%

Latest Earnings

Preliminary Final Report

12 February 2026

Revenue
$12.00
+21.0% YoY
NPAT
-$12.60
-16.0% YoY
EPS
$-0.02

Oneview Healthcare reported strong 21% revenue growth to €12.0M for FY2025, with recurring revenue up 7% to €7.7M, but losses widened 16% to €12.6M. The healthcare software company added 1,469 new endpoints to reach 14,880 total live endpoints and recently joined a Top 10 US health system's purchasing group. Management is focused on cost discipline while pursuing revenue growth to achieve cash flow breakeven, though additional capital funding will be needed. Key points: Strong 21% revenue growth to €12.0M with recurring revenue up 7% to €7.7M; Added 1,469 new endpoints to reach 14,880 total live endpoints across customer base; Four new customers added in 2025, plus recent addition to Top 10 US health system purchasing group

Recent Announcements

12 Feb 2026 Supplementary Neutral

Investor Presentation - Preliminary Final Report 2025

Oneview Healthcare reported 21% revenue growth to €12.0M (A$21.0M) driven by new customer deployments, despite operating losses continuing at €11.0M. The company added 4 new customer logos and expanded live endpoints 11% to 14,880, while introducing AI-powered solutions through their new Ovie ecosystem to enhance patient experience and operational efficiency. Key points: Strong 21% revenue growth driven by new customer deployments; Added to GPO of Top 10 US Health System providing scalable pathway for growth; Live endpoints grew 11% to 14,880 with 31% acceleration in deployment activity in H2

12 Feb 2026 Actual Results Neutral

Preliminary Final Report

Oneview Healthcare reported strong 21% revenue growth to €12.0M for FY2025, with recurring revenue up 7% to €7.7M, but losses widened 16% to €12.6M. The healthcare software company added 1,469 new endpoints to reach 14,880 total live endpoints and recently joined a Top 10 US health system's purchasing group. Management is focused on cost discipline while pursuing revenue growth to achieve cash flow breakeven, though additional capital funding will be needed. Key points: Strong 21% revenue growth to €12.0M with recurring revenue up 7% to €7.7M; Added 1,469 new endpoints to reach 14,880 total live endpoints across customer base; Four new customers added in 2025, plus recent addition to Top 10 US health system purchasing group

Get real-time alerts for ONE

Receive AI-powered earnings summaries and instant notifications when Oneview Healthcare Plc releases results.

Register Free